Evidence map›Paper›PMID 33078597›Full record

ArticleJournal of gynecologic oncology2020

Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups.

Giorgio Bogani, Giovanni Apolone, Antonino Ditto, Giovanni Scambia, Pierluigi Benedetti Panici, Roberto Angioli, Sandro Pignata, Stefano Greggi, Paolo Scollo, Mezzanzanica Delia and 28 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of gynecologic oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Patient Voices: What Can We Learn From the Covid-19 Pandemic About Follow-Up Care in Gynaecologic Oncology?Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  4. Global determinants of gynecologic cancer incidence and mortality: A cluster-based analysis with predictive insights.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 19 institutions in 2 countries.

Giorgio BoganiFondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. giorgiobogani@yahoo.it.ORCID 0000-0001-8373-8569
Giovanni ApoloneFondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0001-5179-104X
Antonino DittoFondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-5684-8225
Giovanni ScambiaUOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy.ORCID 0000-0002-9503-9041
Pierluigi Benedetti PaniciDepartment of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.ORCID 0000-0001-6752-2039
Roberto AngioliDepartment of Gynecology, Università Campus Bio-Medico, Rome, Italy.ORCID 0000-0002-8528-4318
Sandro PignataUrogynaecological Medical Oncology Unit Istituto Nazionale Tumori, IRCCS, Naples, Italy.ORCID 0000-0002-8836-2633
Stefano GreggiUrogynaecological Medical Oncology Unit Istituto Nazionale Tumori, IRCCS, Naples, Italy.ORCID 0000-0001-5601-5111
Paolo ScolloDepartment of Gynecology, Cannizzaro Hospital, Catania, Italy.ORCID 0000-0002-5577-616X
Mezzanzanica DeliaFondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-9664-6871
Massimo FranchiDepartment of Obstetrics and Gynaecology, AOUI Verona, University of Verona, Verona, Italy.ORCID 0000-0002-5265-2161
Fabio MartinelliFondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-4863-1747
Mauro SignorelliFondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-5568-5233
Salvatore LopezFondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0001-7705-3715
Violante Di DonatoDepartment of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-9254-5790
Giorgio ValabregaCandiolo Cancer Institute, FPO, IRCCS, Candiolo, Italy.ORCID 0000-0001-5444-6305
Gabriella FerrandinaUOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy.ORCID 0000-0003-4672-4197
Innocenza PalaiaDepartment of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.ORCID 0000-0003-2346-8696
Alice BergaminiObstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0002-1915-8313
Luca BoccioloneObstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-5098-0500
Antonella SavareseOncologia Medica 1, IRCCS Istituto Nazionale Tumori Regina Elena, Roma, Italy.ORCID 0000-0003-0011-6276
Fabio GhezziDepartment of Obstetrics and Gynecology, University of Insubria, Varese, Italy.ORCID 0000-0003-3949-5410
Jvan CasarinDepartment of Obstetrics and Gynecology, University of Insubria, Varese, Italy.ORCID 0000-0001-9519-1097
Ciro PinelliDepartment of Obstetrics and Gynecology, University of Insubria, Varese, Italy.ORCID 0000-0003-2375-9522
Vito TrojanoDepartment of Obstetrics and Gynaecology, Mater Dei Hospital, Bari, Italy.ORCID 0000-0002-5543-0150
Vito ChianteraDepartment of Gynecologic Oncology, University of Palermo, Palermo, Italy.ORCID 0000-0002-6294-3720
Giorgio GiordaGynaecological Oncology Unit, Centro di Riferimento Oncologico (CRO) di Aviano, IRCCS, Aviano, Italy.ORCID 0000-0001-6386-3565
Francesco SopracordevoleGynaecological Oncology Unit, Centro di Riferimento Oncologico (CRO) di Aviano, IRCCS, Aviano, Italy.ORCID 0000-0001-5562-4353
Mario MalzoniEndoscopica Malzoni, Center for Advanced Endoscopic Gynecological Surgery, Avellino, Italy.ORCID 0000-0003-2514-7159
Giovanna SalernoDepartment of Gynecology, San Camillo-Forlanini Hospital, Rome, Italy.ORCID 0000-0002-7463-7085
Enrico SartoriDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.ORCID 0000-0003-4076-303X
Antonia TestaUOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy.ORCID 0000-0003-2217-8726
Gianfranco ZannoniUOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy.ORCID 0000-0003-1809-129X
Fulvio ZulloGynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.ORCID 0000-0003-4006-3287
Enrico VizzaGynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.ORCID 0000-0001-5975-1202
Giuseppe TrojanoDepartment of Obstetrics and Gynecology, University Medical School "A. Moro", Bari, Italy.ORCID 0000-0002-8737-9943
Antonio ChianteraPresident of the Scientific Society, Italian Society of Gynecology and Obstetrics (SIGO), Bologna, Italy.ORCID 0000-0002-4349-4237
Francesco RaspagliesiFondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0001-8953-1657
Fondazione IRCCS Istituto Nazionale dei Tumori · ITAgostino Gemelli University Polyclinic · ITSapienza University of Rome · ITUniversity of Insubria · ITCentro di Riferimento Oncologico · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITVita-Salute San Raffaele University · ITCandiolo Cancer Institute · ITCarlo Forlanini Hospital · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITOspedale Cannizzaro · ITSocietà Italiana di Fisica · ITTumori Foundation · USUniversità Campus Bio-Medico · ITUniversity of Bari Aldo Moro · ITUniversity of Brescia · ITUniversity of Naples Federico II · ITUniversity of Palermo · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCoronavirus disease 2019 (COVID-19) has caused rapid and drastic changes in cancer management. The Italian Society of Gynecology and Obstetrics (SIGO), and the Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) promoted a national survey aiming to evaluate the impact of COVID-19 on clinical activity of gynecologist oncologists and to assess the implementation of containment measures against COVID-19 diffusion.

methodsThe survey consisted of a self-administered, anonymous, online questionnaire. The survey was sent via email to all the members of the SIGO, and MITO groups on April 7, 2020, and was closed on April 20, 2020.

resultsOverall, 604 participants completed the questionnaire with a response-rate of 70%. The results of this survey suggest that gynecologic oncology units had set a proactive approach to COVID-19 outbreak. Triage methods were adopted in order to minimize in-hospital diffusion of COVID-19. Only 38% of gynecologic surgeons were concerned about COVID-19 outbreak. Although 73% of the participants stated that COVID-19 has not significantly modified their everyday practice, 21% declared a decrease of the use of laparoscopy in favor of open surgery (19%). However, less than 50% of surgeons adopted specific protection against COVID-19. Additionally, responders suggested to delay cancer treatment (10%-15%), and to perform less radical surgical procedures (20%-25%) during COVID-19 pandemic.

conclusionsNational guidelines should be implemented to further promote the safety of patients and health care providers. International cooperation is of paramount importance, as heavily affected nations can serve as an example to find out ways to safely preserve clinical activity during the COVID-19 outbreak.

Indexed as

BetacoronavirusCoronavirus InfectionsCOVID-19FemaleGenital Neoplasms, FemaleGynecologic Surgical ProceduresGynecologyHumansInfection ControlInternational CooperationItalyMedical OncologyPandemicsPneumonia, ViralSARS-CoV-2Societies, MedicalCOVID-19Health Care SurveysSARS-CoV-2 InfectionSurgical Oncology

Identifiers

PMID33078597
PMCPMC7593217
OpenAlexW3084342544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.